Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 341 through 350 of 424 results (Download Results)

Show results per page

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Richard, Stéphane | Lady Davis Institute for Medical Research | Operating Grant | $309,250

CIHR Quebec 2021

Developing a novel vaccine against COVID-19

Divangahi, Maziar | McGill University | Project Grant | $569,925

CIHR Quebec 2021

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

Xing, Zhou | McMaster University | Operating Grant | $50,000

CIHR Ontario 2021

Proof of concept of wastewater-based surveillance for SARS-COV2 to mitigate secondary COVID‑19 disease transmission in First Nations in Alberta

Parkins, Michael D | The University of Calgary | Other | $200,000

CIHR Alberta 2021

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

Tremblay, Jacques P | Université Laval | Operating Grant | $199,125

CIHR Quebec 2021

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000

CIHR Ontario 2021

Overcoming emerging COVID‑19 challenges with relatable science: Developing and evaluating knowledge tools for Canadians

Scott, Shannon D | University of Alberta | Operating Grant | $272,470

CIHR Alberta 2021

COVID-19 Variant Supplement – Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

Watts, Tania H | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

Provision of services for trauma- and stressor-related (TSR) disorders during a pandemic: Investigating the Utility of Reconsolidation Therapy Delivered Online

Brunet, Alain F | CIUSSS de l'Ouest-de-l'Ile-de-Montréal-Douglas Hospital | Project Grant | $240,975

CIHR Quebec 2021

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Côté, Marceline | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Errant epitopes from arginine methylated SARS-CoV-2 proteins predisposing to autoimmune diseases.

Developing a novel vaccine against COVID-19

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

Proof of concept of wastewater-based surveillance for SARS-COV2 to mitigate secondary COVID‑19 disease transmission in First Nations in Alberta

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Overcoming emerging COVID‑19 challenges with relatable science: Developing and evaluating knowledge tools for Canadians

COVID-19 Variant Supplement – Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

Provision of services for trauma- and stressor-related (TSR) disorders during a pandemic: Investigating the Utility of Reconsolidation Therapy Delivered Online

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals